Allworth Financial LP Cuts Position in STERIS plc (NYSE:STE)

Allworth Financial LP reduced its holdings in shares of STERIS plc (NYSE:STE) by 9.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 590 shares of the medical equipment provider’s stock after selling 61 shares during the quarter. Allworth Financial LP’s holdings in STERIS were worth $129,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in STE. Creative Planning boosted its holdings in STERIS by 1.4% in the third quarter. Creative Planning now owns 9,019 shares of the medical equipment provider’s stock valued at $2,187,000 after purchasing an additional 126 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of STERIS by 25.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock valued at $2,005,000 after purchasing an additional 1,713 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of STERIS by 32.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock valued at $1,869,000 after buying an additional 1,904 shares during the last quarter. Boston Trust Walden Corp grew its position in shares of STERIS by 0.3% during the third quarter. Boston Trust Walden Corp now owns 44,912 shares of the medical equipment provider’s stock worth $10,893,000 after buying an additional 118 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its stake in shares of STERIS by 6.9% in the third quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock worth $2,778,000 after buying an additional 735 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on STE. Stephens reiterated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, November 8th. Finally, Piper Sandler increased their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Stock Down 0.2 %

Shares of STERIS stock opened at $220.43 on Monday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The stock has a 50-day moving average price of $213.59 and a 200 day moving average price of $223.33. The company has a market cap of $21.66 billion, a P/E ratio of 46.80 and a beta of 0.84.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.